AtriCure Inc

ATRC

Company Profile

  • Business description

    AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.

  • Contact

    7555 Innovation Way
    MasonOH45040
    USA

    T: +1 513 755-4100

    E: [email protected]

    https://www.atricure.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Instruments & Supplies

    Fiscal Year End

    31 December 2026

    Employees

    1,350

Stocks News & Analysis

stocks

ASX biotech expands diagnostics portfolio after FDA approval

FDA nod adds another growth driver for ASX share.
stocks

Is it time to bail on Australian stocks?

Is your home bias costing your portfolio better returns?
stocks

ASX share undervalued despite margin woes

Short term margin pressure yet shares remain undervalued on improved outlook.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,849.3074.60-0.84%
CAC 408,090.2827.50-0.34%
DAX 4025,402.2838.53-0.15%
Dow JONES (US)52,093.11328.09-0.63%
FTSE 10010,658.1339.44-0.37%
HKSE24,667.24250.36-1.00%
NASDAQ25,981.57204.84-0.78%
Nikkei 22563,484.108.89-0.01%
NZX 50 Index13,484.2276.47-0.56%
S&P 5007,585.7334.25-0.45%
S&P/ASX 2008,672.5077.40-0.88%
SSE Composite Index3,864.2821.05-0.54%

Market Movers